-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Axsome Therapeutics, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2022 to Q3 2025.
- Axsome Therapeutics, Inc. Selling and Marketing Expense for the quarter ending September 30, 2025 was $114M, a 67.5% increase year-over-year.
- Axsome Therapeutics, Inc. Selling and Marketing Expense for the twelve months ending September 30, 2025 was $385M.
- Axsome Therapeutics, Inc. annual Selling and Marketing Expense for 2024 was $293M, a 23.7% increase from 2023.
- Axsome Therapeutics, Inc. annual Selling and Marketing Expense for 2023 was $237M, a 127% increase from 2022.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)